Latest Issue
PharmTech
Latest Issue
PharmTech Europe
|
|
- Topics
- Publications
- Archives
- Multimedia
- Whitepapers
- The Marketplace
- eNewsletters
-
Email Newsletters from Pharmaceutical Technology and Pharmaceutical Technology Europe 
News from Europe's pharmaceutical manufacturing industry coupled with upcoming events, and exclusive articles and interviews from industry experts.
WEEKLY
Subscribe
-
|
Industry Briefs: Jan. 30, 2012
Company News Aptar Pharma has opened a new manufacturing site near Mumbai, India. Read More FDA has approved Pfizer’s Inlyta (axitinib), a kinase inhibitor for treating advanced renal cell carcinoma. Read More FDA has approved Roche’s Erivedge (vismodegib) capsule for treating advanced basal cell carcinoma. Read More Lpath has temporarily suspended dosing of iSONEP, for treating age-related macular degeneration, in clinical trials due to cGMP compliance issues at the contract fill–finish source. Read More Roche has formally issued an offer to acquire all outstanding shares of Illumina for $44.50 per share in cash, or an aggregate of approximately $5.7 billion. Read More Royal DSM and Indoco Remedies have formed a commercialization agreement for eight APIs. Read More Valeant Pharmaceuticals has withdrawn its offer to acquire ISTA Pharmaceuticals for $7.50 per share in cash. Read More Watson Pharmaceuticals announced plans to establish a New Jersey-based R&D technology center to support generic-drug pharmaceutical product development. Read More People News GlaxoSmithKline has announced changes to its board of directors. Read More Octagon Research Solutions has appointed Gina L. Schmidt to manage the company’s global regulatory services division. Read More
|
|
|||||||||||||||
